Study provides insight on how to build a better flu vaccine

August 31, 2020

Flu season comes around like clockwork every year, and sooner or later everyone gets infected. The annual flu shot is a key part of public health efforts to control the flu, but the vaccine's effectiveness is notoriously poor, falling somewhere from 40% to 60% in a typical year.

A growing body of evidence suggests that a history of exposure to influenza virus might be undermining the effectiveness of the annual flu vaccine. Partial immunity developed during prior flu seasons -- either through natural infection or vaccination -- might interfere with the body's response to a new vaccine, such that vaccination mainly boosts the recognition of prior influenza strains but does little to create the ability to fight new strains.

Now, a team led by researchers at Washington University School of Medicine in St. Louis has developed an approach to assess whether a vaccine activates the kind of immune cells needed for long-lasting immunity against new influenza strains. Using this technique, the researchers showed that the flu vaccine is capable of eliciting antibodies that protect against a broad range of flu viruses, at least in some people. The findings, published Aug. 31 in the journal Nature, could aid efforts to design an improved flu vaccine that provides protection not only against old influenza viruses but also new ones.

"Every year, about half of the U.S. adult population gets vaccinated against influenza," said senior author Ali Ellebedy, PhD, an assistant professor of pathology and immunology at Washington University. "It's necessary for public health, but it's also incredibly expensive and inefficient. What we need is a one-and-done influenza shot, but we are not there yet. Anything that helps us understand how immunity develops in the context of prior exposures would be important as we try to make a better vaccine."

The key to long-lasting immunity lies in lymph nodes, minuscule organs of the immune system positioned throughout the body. Easy to miss in healthy people, lymph nodes become swollen and tender during an infection as immune cells busily interact and multiply within them.

The first time a person is exposed to a virus - either by infection or vaccination - immune cells capture the virus and bring it to the nearest lymph node. There, the virus is presented to so-called naïve B cells, causing them to mature and start producing antibodies to fight the infection. Once the virus is successfully routed, most of the immune cells that take part in the battle die off, but a few continue circulating in the blood as long-lived memory B cells.

The second time a person is exposed to a virus, memory B cells quickly reactivate and start producing antibodies again, bypassing naive B cells. This rapid response quickly builds protection for people who have been reinfected with the exact same strain of virus, but it's not ideal for people who have received a vaccine designed to build immunity against a slightly different strain, as in the annual flu vaccine.

"If our influenza vaccine targets memory cells, those cells will respond to the parts of the virus that haven't changed from previous influenza strains," Ellebedy said. "Our goal is to get our immune system up to date with the new strains of influenza, which means we want to focus the immune response on the parts of the virus that are different this year."

To get decades-long immunity against the new strains, the flu strains from the vaccine need to be taken to the lymph nodes, where they can be used to train a new set of naïve B cells and induce long-lived memory B cells specifically tailored to recognize the unique features of the vaccine strains.

To find out what happens inside lymph nodes after influenza vaccination, Ellebedy enlisted the help of co-authors Rachel Presti, MD, PhD, an associate professor of medicine, and Sharlene Teefey, MD, a professor of radiology at Washington University. Presti led a team at the Infectious Disease Clinical Research Unit that coordinated the sampling of blood and lymph nodes from healthy volunteers before and after vaccination. Guided by ultrasound imaging, Teefey carefully extracted so-called germinal centers that hold immune cells from underarm lymph nodes of eight healthy, young volunteers vaccinated with the 2018-19 quadrivalent influenza vaccine. That vaccine was designed to protect against four different strains of influenza virus. The immune cells were extracted at one, two, four and nine weeks after vaccination.

Ellebedy and colleagues ­- including co-senior authors Steven Kleinstein, PhD, a professor of pathology at Yale University School of Medicine, and Andrew Ward, PhD, a professor of integrative structural and computational biology at Scripps Research Institute, as well as co-first authors Jackson Turner, PhD, a postdoctoral researcher who works with Ellebedy, Julian Zhou, a graduate student in Kleinstein's lab, and Julianna Han, PhD, a postdoctoral scholar who works with Ward - analyzed the immune cells in the germinal centers to find the ones that had been activated by vaccination.

In three volunteers, both memory B cells and naïve B cells in the lymph nodes responded to the vaccine strains, indicating that the vaccine had initiated the process of inducing long-lasting immunity against the new strains.

"Our study shows that the influenza vaccine can engage both kinds of cells in the germinal centers, but we still don't know how often that happens," Ellebedy said. "But given that influenza vaccine effectiveness hovers around 50%, it probably doesn't happen as often as we would like. That brings up the importance of promoting strategies to boost the germinal centers as a step toward a universal influenza vaccine."

Washington University School of Medicine

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to